Why the latest brenetafusp data matters for Immunocore Holdings (NasdaqGS:IMCR) Immunocore Holdings (NasdaqGS:IMCR) drew market interest after presenting updated clinical results for its ...

View Immunocore Holdings Plc Shs Sponsored American Depositary Shares Repr 1 Sh IMCR stock quote prices, financial information, real-time forecasts, and company news from CNN.

Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma Brenetafusp monotherapy resulted in a 6-month overall survival rate of 87% and disease ...

Immunocore Hldgs (NASDAQ:IMCR) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the ...

Ratings for Immunocore Hldgs (NASDAQ:IMCR) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of ...

OXFORD, England and INDIANAPOLIS, July 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Immunocore Limited today announced they have entered into a co-discovery and co-development ...

Revenue (GAAP) rose 30% to $98.0 million in the quarter, topping GAAP revenue estimates by $5.85 million. Earnings per share (GAAP) of $(0.20) missed GAAP EPS estimates due to higher R&D and SG&A ...

Dr. Mohammed Dar, Chief Medical Officer, and Mark Moyer, Head of Regulatory Sciences, promoted to Executive Vice President roles (OXFORDSHIRE, England & RADNOR, Penn. & GAITHERSBURG, Md., US, 30 ...

OXFORD, United Kingdom--(BUSINESS WIRE)--Immunocore, a world-leading biotechnology company developing novel T cell receptor (TCR) based biological drugs to treat cancer, infectious diseases and ...

DUBLIN (Reuters) - Immunocore completed Europe's largest ever financing round by a private life sciences company on Thursday, raising $320 million from investors including Eli Lilly & Co (LLY.N), ...